The U.S. Pharmacy Market continues to evolve rapidly, fueled by technological innovations, strategic mergers, and a growing demand for pharmaceutical products. This comprehensive analysis explores the current state of the market, highlighting key companies, recent developments, drivers, restraints, and future opportunities. The U.S. pharmacy market plays a critical role in ensuring the safe and efficient delivery of medications to millions of patients across the country. With a growing demand for prescription drugs and healthcare services, pharmacies are becoming increasingly important in chronic disease management, preventive care, and medication counseling.
According to Fortune Business Insights, the U.S. pharmacy market was valued at USD 534.21 billion in 2020 and is projected to grow from USD 560.00 billion in 2021 to USD 861.67 billion by 2028, exhibiting a CAGR of 6.3% during the 2021-2028 period.
In June 2021, AmerisourceBergen Corporation and Walgreens Boots Alliance, Inc. successfully completed their previously announced strategic agreements. Under this deal, AmerisourceBergen acquired the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses, significantly strengthening its pharmaceutical distribution capabilities and extending its global reach.